ISCO - International Stem Cell Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
5.91M
Enterprise Value 3
13.06M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.67
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
1.47
Enterprise Value/EBITDA 6
-3.42

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 3-46.79%
S&P500 52-Week Change 325.89%
52 Week High 31.6000
52 Week Low 30.3500
50-Day Moving Average 30.5782
200-Day Moving Average 30.6265

Share Statistics

Avg Vol (3 month) 35.2k
Avg Vol (10 day) 317.2k
Shares Outstanding 57.53M
Float 3.23M
% Held by Insiders 167.97%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:150
Last Split Date 3Jul 28, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -29.13%
Operating Margin (ttm)-46.43%

Management Effectiveness

Return on Assets (ttm)-30.27%
Return on Equity (ttm)-80.50%

Income Statement

Revenue (ttm)8.86M
Revenue Per Share (ttm)1.21
Quarterly Revenue Growth (yoy)-34.40%
Gross Profit (ttm)7.02M
EBITDA -3.82M
Net Income Avi to Common (ttm)-2.58M
Diluted EPS (ttm)-0.3520
Quarterly Earnings Growth (yoy)-97.50%

Balance Sheet

Total Cash (mrq)463k
Total Cash Per Share (mrq)0.06
Total Debt (mrq)2.96M
Total Debt/Equity (mrq)81.82
Current Ratio (mrq)0.88
Book Value Per Share (mrq)-0.09

Cash Flow Statement

Operating Cash Flow (ttm)-825k
Levered Free Cash Flow (ttm)-2.28M